WallStreetZenWallStreetZen

NASDAQ: SGMT
Sagimet Biosciences Inc Stock Ownership - Who owns Sagimet Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sagimet Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
George KembleExecutive Chairman2025-11-2037,688$7.69
$289.97kSell
David HappelPresident CEO2025-07-2165,478$9.14
$598.14kSell
Eduardo Bruno MartinsChief Medical Officer2025-07-218,277$9.14
$75.61kSell
Elizabeth RozekGeneral Counsel and CCO2025-07-2110,780$9.14
$98.48kSell

1 of 1

SGMT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGMT insiders and whales buy or sell their stock.

SGMT Shareholders

What type of owners hold Sagimet Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick J. Kerins9.27%3,013,414$21.33MInsider
Forest Baskett9.26%3,011,575$21.32MInsider
Scott D. Sandell9.25%3,007,272$21.29MInsider
New Enterprise Associates 13 LP9.23%3,000,275$21.24MInsider
Nea Partners 13 Limited Partnership9.23%3,000,275$21.24MInsider
Beth C. Seidenberg6.25%2,031,118$14.38MInsider
Kpcb Pbd Associates LLC5.84%1,899,475$13.45MInsider
Jinzi Jason Wu5.09%1,654,701$11.72MInsider
Woodline Partners LP4.62%1,501,357$10.63MInstitution
Blue Owl Capital Holdings LP4.08%1,328,351$9.40MInstitution

1 of 3

SGMT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGMT36.57%63.43%Net SellingNet Selling
MDWD44.91%0.00%
CABA71.90%4.39%
ETHZ71.71%28.29%Net Buying
TNYA20.74%22.99%Net BuyingNet Selling
View Top Biotech Stocks

Sagimet Biosciences Stock Ownership FAQ

Who owns Sagimet Biosciences?

Sagimet Biosciences (NASDAQ: SGMT) is owned by 38.51% institutional shareholders, 66.79% Sagimet Biosciences insiders, and 0.00% retail investors. Patrick J. Kerins is the largest individual Sagimet Biosciences shareholder, owning 3.01M shares representing 9.27% of the company. Patrick J. Kerins's Sagimet Biosciences shares are currently valued at $21.33M.

If you're new to stock investing, here's how to buy Sagimet Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.